CA3061893A1 - Selenium containing pharmaceutical agents, compositions, and methods relating thereto - Google Patents

Selenium containing pharmaceutical agents, compositions, and methods relating thereto Download PDF

Info

Publication number
CA3061893A1
CA3061893A1 CA3061893A CA3061893A CA3061893A1 CA 3061893 A1 CA3061893 A1 CA 3061893A1 CA 3061893 A CA3061893 A CA 3061893A CA 3061893 A CA3061893 A CA 3061893A CA 3061893 A1 CA3061893 A1 CA 3061893A1
Authority
CA
Canada
Prior art keywords
compound
insulin
glucose
cells
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3061893A
Other languages
English (en)
French (fr)
Inventor
Zi-Jian LAN
Ronan Power
Alexandros Yiannikouris
Thirupathi Reddy Yerramreddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alltech Corp
Original Assignee
Alltech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Corp filed Critical Alltech Corp
Publication of CA3061893A1 publication Critical patent/CA3061893A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA3061893A 2017-05-19 2018-05-01 Selenium containing pharmaceutical agents, compositions, and methods relating thereto Pending CA3061893A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762508730P 2017-05-19 2017-05-19
US62/508,730 2017-05-19
PCT/US2018/030371 WO2018212980A1 (en) 2017-05-19 2018-05-01 Pharmaceutical agents, compositions, and methods relating thereto

Publications (1)

Publication Number Publication Date
CA3061893A1 true CA3061893A1 (en) 2018-11-22

Family

ID=64274560

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3061893A Pending CA3061893A1 (en) 2017-05-19 2018-05-01 Selenium containing pharmaceutical agents, compositions, and methods relating thereto

Country Status (11)

Country Link
US (2) US11014954B2 (enExample)
EP (1) EP3624809A4 (enExample)
JP (1) JP7224303B2 (enExample)
CN (2) CN120647702A (enExample)
AU (1) AU2018269403B2 (enExample)
CA (1) CA3061893A1 (enExample)
NZ (1) NZ758538A (enExample)
RU (1) RU2765286C2 (enExample)
SA (1) SA519410561B1 (enExample)
SG (1) SG11201909932YA (enExample)
WO (1) WO2018212980A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ758538A (en) * 2017-05-19 2025-08-29 Alltech Inc Pharmaceutical agents, compositions, and methods relating thereto

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002305073A1 (en) * 2001-03-22 2002-10-08 Research Foundation Of The City University Of New York Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
US20030078232A1 (en) 2001-08-08 2003-04-24 Elfatih Elzein Adenosine receptor A3 agonists
EP1652519A1 (en) 2004-10-28 2006-05-03 Tamie Nasu Seleniferous composition for producing antioxidase in vivo
US20060198906A1 (en) 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US20070077238A1 (en) 2005-10-04 2007-04-05 Teo Alex Y Production of organic and inorganic selenium compounds by lactic acid bacteria
ES2358351T3 (es) 2005-10-13 2011-05-09 Cv Therapeutics, Inc. Agonistas del receptor de adenosina a1.
EP2192905A4 (en) 2007-08-29 2010-11-10 Adam Lubin METHOD FOR SELECTIVE THERAPY OF DISEASE
WO2013151975A1 (en) 2012-04-02 2013-10-10 Northeastern University Compositions and methods for the inhibition of methyltransferases
CN114533753A (zh) 2013-03-15 2022-05-27 全技术公司 含硒组合物及其治疗和预防与线粒体功能障碍有关的疾病或病症的应用
AU2014386236B2 (en) * 2014-03-14 2019-07-11 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
US20160090397A1 (en) 2014-09-30 2016-03-31 Northeastern University Se-Adenosyl-L-Selenohomocysteine Selenoxide As A Modulator Of Methyltransferase And Other Activities
WO2017048252A1 (en) * 2015-09-15 2017-03-23 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
NZ758538A (en) 2017-05-19 2025-08-29 Alltech Inc Pharmaceutical agents, compositions, and methods relating thereto

Also Published As

Publication number Publication date
EP3624809A4 (en) 2021-03-03
RU2765286C2 (ru) 2022-01-28
RU2019134865A3 (enExample) 2021-06-30
JP2020520904A (ja) 2020-07-16
US11613552B2 (en) 2023-03-28
NZ758538A (en) 2025-08-29
AU2018269403B2 (en) 2025-03-27
JP7224303B2 (ja) 2023-02-17
BR112019022918A2 (pt) 2020-05-26
EP3624809A1 (en) 2020-03-25
CN110545822A (zh) 2019-12-06
SA519410561B1 (ar) 2024-03-06
RU2019134865A (ru) 2021-06-21
CN120647702A (zh) 2025-09-16
SG11201909932YA (en) 2019-11-28
US20200123191A1 (en) 2020-04-23
WO2018212980A1 (en) 2018-11-22
US11014954B2 (en) 2021-05-25
US20210238216A1 (en) 2021-08-05
AU2018269403A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
AU2016222315B2 (en) Compositions of selenoorganic compounds and methods of use thereof
US20140179779A1 (en) Deuterium Substituted Fumarate Derivatives
EP2456304B1 (en) Methods of modulation of branched chain acids and uses thereof
JP7637050B2 (ja) 少なくとも１つのグリシン又はその誘導体と、少なくとも１つのｎ－アセチルシステイン又はその誘導体と、少なくとも１つのニコチンアミドリボシド又はｎａｄ＋前駆体と、を使用する組成物及び方法
US20220267780A1 (en) Conjugates of bile acids and their derivatives for active molecules delivery
EP4244221B1 (en) Prodrug of pyrrolidone derivatives as glucokinase activator
WO2004050122A1 (ja) 高血糖症に起因する疾患の予防又は治療剤
US11613552B2 (en) Pharmaceutical agents, compositions, and methods relating thereto
HK40017181A (en) Pharmaceutical agents, compositions, and methods relating thereto
CN110799518B (zh) 钴胺素衍生物及其用于治疗因缺乏维生素b12供应引起的疾病的用途
BR112019022918B1 (pt) Compostos farmacêuticos contendo selênio para modulação do metabolismo da glicose, composições farmacêuticas e seus usos
EP4487698A1 (en) A micronutrient composition to prevent and reverse protein glycation during oxidative stress in human
EP3144001B1 (en) Compositions of selenoorganic compounds and methods of use thereof
EP4616853A1 (en) Lipo-hydroxamic acid derivative and pharmaceutical use thereof
US20230346765A1 (en) Methods of treating xanthine oxidase-related diseases with niflumic acid and derivatives thereof
EP4615462A1 (en) Methods and compositions for treating wolfram syndrome
US20190040014A1 (en) Solid Forms of an S-Nitrosoglutathione Reductase Inhibitor
HK1235284B (en) Compositions of selenoorganic compounds and methods of use thereof
HK1235284A1 (en) Compositions of selenoorganic compounds and methods of use thereof
AU2003262286A2 (en) Novel Effectors of Dipeptidyl Peptidase IV

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220920

EEER Examination request

Effective date: 20220920

EEER Examination request

Effective date: 20220920

EEER Examination request

Effective date: 20220920

EEER Examination request

Effective date: 20220920

EEER Examination request

Effective date: 20220920

EEER Examination request

Effective date: 20220920